• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肌少症与免疫治疗相关的炎症

Sarcopenia and Inflammation with Immunotherapy.

机构信息

Edirne Sultan I. Murat State Hospital, Clinic of Medical Oncology, Edirne, Turkey.

Haydarpaşa Numune Training and Research Hospital, Clinic of Medical Oncology, İstanbul, Turkey.

出版信息

Oncologist. 2020 May;25(5):e875. doi: 10.1634/theoncologist.2019-1005. Epub 2020 Mar 19.

DOI:10.1634/theoncologist.2019-1005
PMID:32191391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7216466/
Abstract

This letter to the editor presents possible limitations of the study reported by Bilen et al., which might have affected the reported results.

摘要

这封给编辑的信提出了 Bilen 等人报告的研究可能存在的局限性，这些局限性可能影响了报告的结果。

相似文献

1
Sarcopenia and Inflammation with Immunotherapy.肌少症与免疫治疗相关的炎症
Oncologist. 2020 May;25(5):e875. doi: 10.1634/theoncologist.2019-1005. Epub 2020 Mar 19.
2
In Reply.回复。
Oncologist. 2020 May;25(5):e876. doi: 10.1634/theoncologist.2020-0059. Epub 2020 Mar 23.
3
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.骨骼肌质量对非小细胞肺癌患者纳武利尤单抗免疫治疗的预测价值：一项“假说生成器”初步报告。
Thorac Cancer. 2019 Feb;10(2):347-351. doi: 10.1111/1759-7714.12965. Epub 2019 Jan 2.
4
Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.全身炎症与肌肉减少症与非转移性结直肠癌患者生存的相关性：来自 C SCANS 研究的结果。
JAMA Oncol. 2017 Dec 1;3(12):e172319. doi: 10.1001/jamaoncol.2017.2319.
5
The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study).炎症在辅助化疗所致肌肉减少症中的作用（伊兹密尔肿瘤学组（IZOG）研究）
Support Care Cancer. 2020 Aug;28(8):3965-3977. doi: 10.1007/s00520-020-05477-y. Epub 2020 Apr 25.
6
Nanobiologics: a real game changer for targeted immunotherapy.纳米生物制剂：靶向免疫疗法的真正变革者。
Cardiovasc Res. 2019 May 1;115(6):e52-e53. doi: 10.1093/cvr/cvz078.
7
Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.根治性胃切除术后肌少症和全身炎症对胃癌患者的预后价值及相关性。
Oncologist. 2019 Nov;24(11):e1091-e1101. doi: 10.1634/theoncologist.2018-0651. Epub 2019 Mar 25.
8
[Aging-related frailty and sarcopenia. The relationship between "inflammaging" and frailty/sarcopenia.].[衰老相关的衰弱和肌肉减少症。“炎症衰老”与衰弱/肌肉减少症之间的关系。]
Clin Calcium. 2018;28(9):1215-1219.
9
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD.肌少症与营养不良相关，但与晚期慢性肾脏病老年人的系统性炎症无关。
Nutrients. 2019 Jun 19;11(6):1378. doi: 10.3390/nu11061378.
10
Sarcopenia correlates with systemic inflammation in COPD.肌肉减少症与慢性阻塞性肺疾病中的全身炎症相关。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 20;12:669-675. doi: 10.2147/COPD.S130790. eCollection 2017.

引用本文的文献

1
Association between Elderly Sarcopenia and Inflammatory Cytokine Interleukin-17: A Cross-Sectional Study.老年肌少症与炎症细胞因子白细胞介素-17 的相关性：一项横断面研究。
Biomed Res Int. 2023 Feb 22;2023:4839210. doi: 10.1155/2023/4839210. eCollection 2023.
2
Validation of a Short Food Frequency Questionnaire to Measure Dietary Intake of a Selection of Micronutrients in Oncology Patients Undergoing Systemic Therapy.验证一种短式食物频率问卷，以测量接受系统治疗的肿瘤患者的特定微量营养素的膳食摄入量。
Nutrients. 2021 Dec 20;13(12):4557. doi: 10.3390/nu13124557.
3
In Reply.回复。
Oncologist. 2020 May;25(5):e876. doi: 10.1634/theoncologist.2020-0059. Epub 2020 Mar 23.

本文引用的文献

1
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.肌肉减少症与全身炎症联合对免疫治疗晚期癌症患者生存的影响。
Oncologist. 2020 Mar;25(3):e528-e535. doi: 10.1634/theoncologist.2019-0751. Epub 2019 Dec 5.
2
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.晚期癌症患者接受免疫治疗后的转移部位与临床结局的关联。
BMC Cancer. 2019 Aug 29;19(1):857. doi: 10.1186/s12885-019-6073-7.
3
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario.癌症患者免疫检查点阻断治疗时的伴随用药：这一新兴临床状况的新见解。
Crit Rev Oncol Hematol. 2019 Oct;142:26-34. doi: 10.1016/j.critrevonc.2019.07.005. Epub 2019 Jul 22.
4
Nutritional Laboratory Markers in Malnutrition.营养不良中的营养实验室指标
J Clin Med. 2019 May 31;8(6):775. doi: 10.3390/jcm8060775.
5
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.晚期癌症患者接受免疫治疗时炎症生物标志物的预后和预测影响。
Cancer. 2019 Jan 1;125(1):127-134. doi: 10.1002/cncr.31778. Epub 2018 Oct 17.
6
PD-1/PD-L1 and immunotherapy for pancreatic cancer.PD-1/PD-L1 与胰腺癌的免疫治疗。
Cancer Lett. 2017 Oct 28;407:57-65. doi: 10.1016/j.canlet.2017.08.006. Epub 2017 Aug 18.
7
Immunotherapy for pancreatic cancer: present and future.胰腺癌的免疫疗法：现状与未来。
Immunotherapy. 2017 Jun;9(7):607-616. doi: 10.2217/imt-2016-0142.